Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pacritinib Combined With a BTK Inhibitor in Relapsed/Refractory Mantle Cell Lymphoma
NCT06675123Phase 1Recruiting
- Sponsor
- City of Hope
- Start
- Sep 2026
- Primary completion
- Mar 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of pacritinib, sponsored by City of Hope. Started Sep 2026; status: recruiting.
02
Drugs
pacritinib
Beyond the preview
Go deeper on NCT06675123.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06675123.